A detailed history of Windsor Advisory Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Windsor Advisory Group, LLC holds 2,269 shares of ABT stock, worth $231,710. This represents 0.73% of its overall portfolio holdings.

Number of Shares
2,269
Previous 2,096 8.25%
Holding current value
$231,710
Previous $231 Million 11.78%
% of portfolio
0.73%
Previous 0.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $18,946 - $20,926
173 Added 8.25%
2,269 $258 Million
Q3 2023

Oct 31, 2023

SELL
$95.53 - $114.62 $10,412 - $12,493
-109 Reduced 4.94%
2,096 $203 Million
Q1 2023

Jun 13, 2023

SELL
$96.86 - $114.01 $98,894 - $116,404
-1,021 Reduced 31.65%
2,205 $223 Million
Q4 2022

Jun 13, 2023

BUY
$95.06 - $111.52 $306,663 - $359,763
3,226 New
3,226 $354 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Windsor Advisory Group, LLC Portfolio

Follow Windsor Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Advisory Group, LLC with notifications on news.